You are probably correct. Gene said China next week but we are talking any day by now. They are probably going to release the news about Patagonia and China together to max the upside for GTHP.
Minister of health from Patagonia is a supporter and a believer in Luviva. Patagonia has a strong commitment to our product and we expect an order for 1 Luviva machine by late 2017 if we provide the disposables for free. In addition, negotiations for China rights are going to well be expect our 3 prospects to pay us more for the rights in China than the entire market cap of the company. Although they can buy the entire company for less than $2mm they plan to pay us 2X our market cap for the rights in China. Furthermore, the meeting with the FDA was delayed again since there is no point in meeting with them. It is obvious they want a much larger data sample and GTHP does not have the resources or time to produce.
Larry.... Kenya next week!!!!!!! Gene is almost certain now. Next week or the week after.... If not Kenya it will be Nigeria. What happened to Bangladesh? Oops I am drifting. Maybe no Kenya order but a PR that the Minister of Health in Patagonia is a true supporter of Luviva. In addition, China is closer than it was 1 month ago :-)!
Pizza and refills delivery any day now.... definitely next week! I am in if we can keep Gene so I can tell him each week that his paycheck is coming any day now.... definitely this week or next!
$2.7mm loss. They are out of cash. Sales less than $100K. Sales down over 50% versus Q3 2014. No worries. Gene is confident they will get Kenya next week :-)
Unfortunately the company is out of money. Since the order from Kenya was never received and we do not have a deal for China, GTHP has two options. Borrow money against the IP (bad) or do another toxic financing deal (worse).
So how do they raise money in December? Get a loan against the IP or dilute the shares even more. Both really bad scenarios as we continue to circle the toilet bowl. New low of 2 cents. Not sure 2 cents holds after conference call despite the fact I expect Gene to promised Kenya and China for the 20th time this year. They are now very very very close? Yeah, right. Each shareholder of GTHP should get a fluff PR describing us as Luviva supporters :-)
BTW, my neighbor across the street is also a supporter of Luviva. He does not plan to buy a machine but he is a supporter just like the Minister from Nigeria. What a charade. Any day now right Gene? Definetely next week, right? Financials will show GTHP is out of money. They need to raise capital by year end. They can pledge the IP or do more toxic financing.... No good options without orders.
Gene says Kenya any day now. This week or next. Keep it to yourself. Do not spread the rumor. It will be an interesting conference call. Just do not know what Gene can say or why will anyone believe him at this point. Just like my local bar. Free beer always tomorrow. Kenya order always next week. Gene has promised Kenya and day now since November 2014.
Gene is so pathetic, I see him as a cartoon character by now. First time CEO and he is clueless. He has grossly over promised and he never delivers. I might have to actually ask a couple questions at the Q&A this time around. Time for some accountability from this clown pretending to be a CEO.
Mr. Cartwright what is the status on Kenya?
We are very very close to getting an order from Kenya this time around. Any day now. Definitely this week or next.
Any Comments on the China Deal?
I am glad you asked the question. We are very very very close to terminating.... oops closing the deal for China. Any day now. Definetly, this month if not next week.
Mr. Cartwright you have promised Kenya for over 12 months and keep telling us about China but you have not closed either one. Why should we believe you now?
This time is different. I am really thinking this week or next on both but do not hold me to it... A definite maybe on both. Very confident that eventually I will be right. We might have to do another financing before then and the stock might be below 1 penny but we will have those deals before 2016. Opps meant 2015 but definitely by 2016 if not next week.
Aquarius is no longer a net seller. It seems another large shareholder decided to close their position before month end. I am hearing Pro Med (look at the 13G from Muskat) was probably doing the selling this week. We need actual news from GTHP. Do not tell me about Kenya or China "any day now". Show me the order or the signed agreement. I think we are close but with GTHP is always tomorrow.
Guided Therapeutics Expands China Rights Negotiations for LuViva(R) Advanced Cervical Scan to Three Potential Partners
8:05 am ET October 27, 2015 (BusinessWire) Print
Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it is now negotiating with three groups for rights to sell LuViva in China and other Asian markets.
The framework of the negotiations is an upfront licensing fee with ongoing royalties in exchange for exclusive right to market and sell LuViva and its single-patient-use disposables. In April, the company announced it had signed a letter of intent with an investor in the company to negotiate the exclusive distribution rights for LuViva in China.
"Once it was announced that LuViva rights for China were in play, additional interested parties came to the table," said Gene Cartwright, CEO and President of Guided Therapeutics. "As a result, we are now in discussions with those additional parties and are working toward a non-dilutive infusion of capital to secure the exclusive rights and an ongoing royalty revenue stream from the world's second largest market."
China is the second largest medical device market in the world, according to the U.S. Department of Commerce. Approximately 390 million Chinese women are between 25 and 64 years old, the prime age for cervical cancer screening. Prior to commercial sales, LuViva would need approval from the Chinese Food and Drug Administration. The Company currently anticipates interim device and disposable sales for clinical study and demonstration purposes. In Hong Kong, the Company believes the time to commercial sales is quicker, with device registration, rather than approval required.
Worldwide, the market for cervical cancer screening and diagnostics, as currently practiced using cytology (Pap test) for primary screening, is estimated at $6 billion and is projected to grow to almost $9 billion by 2020. T
The meeting with the FDA is to determine the size of the study to get approval…. it is going to take another 1 1/2 years to conduct the study, refile the PMA, and get approval… when people realize FDA is not a factor and without the order from Kenya the stock will start to implode IMHO. This is the reason Aquarius had to pump it early this week to try to dump as many shares as they can before the stock moves to @ 1 cent when more dilution is announced in December without the order from Kenya.
"When deciding whether to put any money in the stock or not investors should also note that while yesterday's trading day was extremely positive for GTHP the stock was also influenced by a round of pump emails that were sent out on Sunday. The involved newsletter - PennyStockLocks, Momentum OTC, InsiderStockProvider, were all affiliates of MJ CAPITAL and disclosed a compensation of $11,500. "
Translation, yesterday Aquarius pumped the stock to dispose of more shares.... without the order from Kenya this stock will be trading @ 1 penny by the time they announce the financing at the end of the year. I guess that is why they increased the potential float to 1 billion shares.
"I know the Kenya order will happen and it will be soon, this year for sure". Do they have the order? Has Gene arranged for a trip to Kenya yet? Please explain and provide proof why you are certain. The only thing is certain is that Aquarius will continue to pump the stock and dispose of as many shares as they can before year-end. This is a huge transfer of wealth from owners of the common to owners of the preferred shares. Preferred shares can be converted to common stock at a 20 percent discount. As a result, if shares plunge to 1 penny the preferred shareholders can convert to common at 80 cents. No risk to them and huge dilution for the common shares. At the end of the day owners of the preferred shares might own this company very very cheap. Would not be surprised if Kenya "slides" until they are forced to issue more shares. Currently the company requires $4mm and financing is expected this year. Without Kenya the stock can easily plunge to 1 penny or less when the financing is completed later this year. So... you said you are sure GTHP is going to receive the order for Kenya. Please provide details.
They are selling the common and keeping the warrants. Their blended cost per shares is @5.75 cents. That is the reason the selling is magically lifted @5.7 cents each day.